Brief: Nykode Q2 Operating Loss $11.9 Million
Aug 23 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* Q2 REVENUE USD 5.1 MILLION VERSUS USD 3.4 MILLION YEAR AGO
* Q2 OPERATING LOSS USD 11.9 MILLION VERSUS LOSS USD 10.1
MILLION
YEAR AGO
Source text for Eikon: ID:nObi26M8la
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026